Anna M Kucharska-Newton1, Priya Palta1, Sheila Burgard2, Michael E Griswold3, Jennifer L Lund1, Benjamin D Capistrant4, Stephen B Kritchevsky5, Karen Bandeen-Roche6, B Gwen Windham3. 1. Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill. 2. Collaborative Studies Coordinating Center, Department of Biostatistics, University of North Carolina Gillings School of Global Public Health, Chapel Hill. 3. Department of Medicine, University of Mississippi Medical Center, Jackson. 4. Division of Epidemiology and Community Health, University of Minnesota, Minneapolis. 5. Division of Gerontology and Geriatric Medicine, Department of Medicine, Wake Forest University, Winston-Salem, North Carolina. 6. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Abstract
Background: Factors that may contribute to the development of frailty in late life have not been widely investigated. The Atherosclerosis Risk in Communities (ARIC) Study cohort presents an opportunity to examine relationships of midlife risk factors with frailty in late life. However, we first present findings on the validation of an established frailty phenotype in this predominantly biracial population of older adults. Methods: Among 6,080 participants, we defined frailty based upon the Cardiovascular Health Study (CHS) criteria incorporating measures of weight loss, exhaustion, slow walking speed, low physical activity, and low grip strength. Criterion and predictive validity of the frailty phenotype were estimated from associations between frailty status and participants' physical and mental health status, physiologic markers, and incident clinical outcomes. Results: A total of 393 (6.5%) participants were classified as frail and 50.4% pre-frail, similar to CHS (6.9% frail, 46.6% pre-frail). In age-adjusted analyses, frailty was concurrently associated with depressive symptoms, low self-rated health, low medication adherence, and clinical biomarker levels (ie, cholesterol, hemoglobin A1c, white blood cell count, C-reactive protein, and hemoglobin). During 1-year follow-up, frailty was associated with falls, low physical ability, fatigue, and mortality. Conclusions: These findings support the validity of the CHS frailty phenotype in the ARIC Study cohort. Future studies in ARIC may elucidate early-life exposures that contribute to late-life frailty.
Background: Factors that may contribute to the development of frailty in late life have not been widely investigated. The Atherosclerosis Risk in Communities (ARIC) Study cohort presents an opportunity to examine relationships of midlife risk factors with frailty in late life. However, we first present findings on the validation of an established frailty phenotype in this predominantly biracial population of older adults. Methods: Among 6,080 participants, we defined frailty based upon the Cardiovascular Health Study (CHS) criteria incorporating measures of weight loss, exhaustion, slow walking speed, low physical activity, and low grip strength. Criterion and predictive validity of the frailty phenotype were estimated from associations between frailty status and participants' physical and mental health status, physiologic markers, and incident clinical outcomes. Results: A total of 393 (6.5%) participants were classified as frail and 50.4% pre-frail, similar to CHS (6.9% frail, 46.6% pre-frail). In age-adjusted analyses, frailty was concurrently associated with depressive symptoms, low self-rated health, low medication adherence, and clinical biomarker levels (ie, cholesterol, hemoglobin A1c, white blood cell count, C-reactive protein, and hemoglobin). During 1-year follow-up, frailty was associated with falls, low physical ability, fatigue, and mortality. Conclusions: These findings support the validity of the CHS frailty phenotype in the ARIC Study cohort. Future studies in ARIC may elucidate early-life exposures that contribute to late-life frailty.
Authors: Linda P Fried; Luigi Ferrucci; Jonathan Darer; Jeff D Williamson; Gerard Anderson Journal: J Gerontol A Biol Sci Med Sci Date: 2004-03 Impact factor: 6.053
Authors: M S Yassuda; A Lopes; M Cachioni; D V S Falcao; S S T Batistoni; V V Guimaraes; A L Neri Journal: J Nutr Health Aging Date: 2012-01 Impact factor: 4.075
Authors: B Gwen Windham; Michael E Griswold; Seth Lirette; Anna Kucharska-Newton; Randi E Foraker; Wayne Rosamond; Josef Coresh; Stephen Kritchevsky; Thomas H Mosley Journal: J Gerontol A Biol Sci Med Sci Date: 2015-09-25 Impact factor: 6.053
Authors: Karen Bandeen-Roche; Christopher L Seplaki; Jin Huang; Brian Buta; Rita R Kalyani; Ravi Varadhan; Qian-Li Xue; Jeremy D Walston; Judith D Kasper Journal: J Gerontol A Biol Sci Med Sci Date: 2015-08-21 Impact factor: 6.053
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Carmen C Cuthbertson; Anna Kucharska-Newton; Keturah R Faurot; Til Stürmer; Michele Jonsson Funk; Priya Palta; B Gwen Windham; Sydney Thai; Jennifer L Lund Journal: Epidemiology Date: 2018-07 Impact factor: 4.822
Authors: Andrew B Smitherman; Chelsea Anderson; Jennifer L Lund; Jeannette T Bensen; Donald L Rosenstein; Hazel B Nichols Journal: J Adolesc Young Adult Oncol Date: 2018-03-23 Impact factor: 2.223
Authors: Shoshana H Ballew; Yan Chen; Natalie R Daya; Job G Godino; B Gwen Windham; Mara McAdams-DeMarco; Josef Coresh; Elizabeth Selvin; Morgan E Grams Journal: Am J Kidney Dis Date: 2016-11-22 Impact factor: 8.860
Authors: Keenan A Walker; Jeremy Walston; Rebecca F Gottesman; Anna Kucharska-Newton; Priya Palta; B Gwen Windham Journal: J Gerontol A Biol Sci Med Sci Date: 2019-02-15 Impact factor: 6.053
Authors: Wilson Nadruz; Dalane Kitzman; Beverly Gwen Windham; Anna Kucharska-Newton; Kenneth Butler; Priya Palta; Michael E Griswold; Lynne E Wagenknecht; Gerardo Heiss; Scott D Solomon; Hicham Skali; Amil M Shah Journal: J Gerontol A Biol Sci Med Sci Date: 2017-07-01 Impact factor: 6.053
Authors: Mary R Rooney; Olive Tang; Justin B Echouffo Tcheugui; Pamela L Lutsey; Morgan E Grams; B Gwen Windham; Elizabeth Selvin Journal: Diabetes Care Date: 2021-05-18 Impact factor: 17.152
Authors: Laura M Raffield; Annie Green Howard; Misa Graff; Dan-Yu Lin; Susan Cheng; Ellen Demerath; Chiadi Ndumele; Priya Palta; Casey M Rebholz; Sara Seidelmann; Bing Yu; Penny Gordon-Larsen; Kari E North; Christy L Avery Journal: J Am Heart Assoc Date: 2021-12-10 Impact factor: 6.106
Authors: Colleen M Shannon; Shoshana H Ballew; Natalie Daya; Linda Zhou; Alex R Chang; Yingying Sang; Josef Coresh; Elizabeth Selvin; Morgan E Grams Journal: J Am Geriatr Soc Date: 2021-07-23 Impact factor: 7.538